Report copyright - FY2017 Business Results · Vaccines Make U.S. usiness MTP’s second business pillar (following the domestic market) by achieving revenue of ¥80 billion in Fiscal Year 2020 with
Please pass captcha verification before submit form
Please pass captcha verification before submit form